Katherine Niehaus

Title: Katherine Niehaus: Innovator in Machine Learning for Cancer Diagnostics

Introduction

Katherine Niehaus is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of cancer diagnostics through her innovative use of machine learning technologies. With a total of 2 patents, her work is paving the way for more accurate and efficient diagnostic methods.

Latest Patents

Katherine's latest patents focus on the implementation of machine learning for multi-analyte assay development and testing. These systems and methods analyze blood-based cancer diagnostic tests using multiple classes of molecules. The technology utilizes machine learning (ML) to assess various analytes, such as cell-free DNA, cell-free microRNA, and circulating proteins, extracted from biological samples. By employing multiple assays, including whole-genome sequencing and quantitative immunoassay, her innovations enhance the sensitivity and specificity of diagnostics. The system operates by receiving a biological sample, separating different molecule classes, and identifying feature sets for input into a machine learning model. This process culminates in an output classification that determines whether the sample possesses a specified property.

Career Highlights

Katherine is currently employed at Freenome Holdings, Inc., where she continues to develop cutting-edge technologies in the realm of cancer diagnostics. Her work is instrumental in advancing the capabilities of diagnostic tests, making them more reliable and effective.

Collaborations

Katherine collaborates with talented individuals such as Adam Drake and Daniel Delubac, contributing to a dynamic team focused on innovation in healthcare technology.

Conclusion

Katherine Niehaus is a trailblazer in the field of machine learning applications for cancer diagnostics. Her patents and ongoing work at Freenome Holdings, Inc. exemplify her commitment to improving healthcare outcomes through innovative technology.